Form 8-K - Current report:
SEC Accession No. 0001213900-25-100494
Filing Date
2025-10-21
Accepted
2025-10-20 20:32:55
Documents
14
Period of Report
2025-10-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0261892-8k_profusa.htm   iXBRL 8-K 30068
2 AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ea026189201ex3-1_profusa.htm EX-3.1 13380
3 GRAPHIC ex3-1_001.jpg GRAPHIC 9050
  Complete submission text file 0001213900-25-100494.txt   228663

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nvacw-20251020.xsd EX-101.SCH 3014
5 XBRL LABEL FILE nvacw-20251020_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nvacw-20251020_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0261892-8k_profusa_htm.xml XML 3902
Mailing Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001
Business Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001 212-494-9022
Profusa, Inc. (Filer) CIK: 0001859807 (see all company filings)

EIN.: 863437271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41177 | Film No.: 251405189
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)